Get the app!
Back to Trades

Emergent BioSolutions Inc.

EBSCIK: 0001367644

Emergent BioSolutions Inc. (EBS) has recorded 37 insider filings from 16 unique insiders, totaling $11.8M in trading activity (net selling). Insiders have sold $1.3M while purchasing $0. Insider sales can reflect personal financial planning rather than a bearish view — always consider the full context. The most active insider by volume is LINDAHL RICHARD S. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.

Total Volume
$11.8M
Purchases
$0
Sales
$1.3M
Unique Insiders
16

Recent Insider Trades (37)

Sell
$144.5K
2 sales1 grant
Sell
$128.2K
1 sale1 grant
Harsanyi ZsoltChairman, Director
Filed May 4, 2026
Grant
$0
1 grant
Sell
$115.6K
2 sales1 grant
Sell
$130.0K
2 sales1 grant
Perl JessicaSVP, General Counsel, Corp Sec
Filed May 1, 2026
Grant
$0
1 grant
Hartzel WilliamSVP, Bioservices
Filed May 1, 2026
Grant
$0
1 grant
Lowry Simon CSVP, R&D, CMO
Filed May 1, 2026
Grant
$0
1 grant
Glessner ColeenEVP, Quality & Ethics, and CPL
Filed May 1, 2026
Grant
$0
1 grant
PAPA JOSEPH CPresident and CEO, Director
Filed May 1, 2026
Grant
$0
1 grant
LINDAHL RICHARD SEVP, Chief Financial Officer
Filed May 1, 2026
Grant
$0
1 grant
LINDAHL RICHARD SEVP, Chief Financial Officer
Filed Mar 5, 2026
Other
$0
Glessner ColeenEVP, Quality & Ethics, and CPL
Filed Mar 5, 2026
Other
$0
PAPA JOSEPH CPresident and CEO, Director
Filed Mar 5, 2026
Other
$0
Perl JessicaSVP, General Counsel, Corp Sec
Filed Mar 5, 2026
Other
$0
Perl JessicaSVP, General Counsel, Corp Sec
Filed Feb 10, 2026
Other
$0
Glessner ColeenEVP, Quality & Ethics, and CPL
Filed Feb 10, 2026
Other
$0
LINDAHL RICHARD SEVP, Chief Financial Officer
Filed Feb 10, 2026
Other
$0
LINDAHL RICHARD SEVP, Chief Financial Officer
Filed Oct 17, 2025
Other
$0
Glessner ColeenEVP, Quality & Ethics, and CPL
Filed Oct 16, 2025
Sell
$306.1K
1 sale
LINDAHL RICHARD SEVP, Chief Financial Officer
Filed Mar 6, 2026
Other
$0